Breakthrough in breast cancer research could lead to personalised treatments

Scientists develop new tool to help ‘supercharge’ patient's immune system
Scientists in London have developed a new tool that could lead to improved, personalised treatments for advanced breast cancer (File picture)
PA Wire
Daniel Keane2 May 2024

Scientists in London have developed a new tool that could lead to improved, personalised treatments for advanced breast cancer.

Researchers at the Institute of Cancer Research (ICR) have discovered the key features of B cells which make them successful at targeting tumours - including when cancer has spread to a different part of the body.

B cells are a type of white blood cell that help to protect against infection by creating antibodies. They are key to fighting viruses and cancer.

For the study, the team took biopsies from patients with breast cancer and used a technique called B cell receptor sequencing to identify genetic variations in the B cells.

They focused on the B cells of people with advanced breast cancer who died after their cancer had spread to other parts of the body, as well as patients with early breast cancer being treated with chemotherapy.

The team found that when a receptor on the B cell identifies a cancer cell and binds to it, the B cell undergoes changes to be even more effective at targeting those cancer cells.

Some unique B cells which had changed their genetic sequence after targeting cancer cells were present at multiple sites where the cancer had spread to. This means that, after recognising cancer in one area of the body, B cells migrate to hunt down cancer at different sites around the body.

Researchers used this information to develop a tool to predict which B cells were most likely to successfully detect and target cancer cells.

The tool could be used to find a patient's most successful anti-cancer B cells and artificially develop the antibodies that these B cells create.

It is hoped this could then be given as a personalised immunotherapy treatment which could "supercharge" a patient's immune system.

Dr Stephen-John Sammut, first author on the study and leader of the Cancer Dynamics Group at the ICR, said: "The computational tool we have developed will allow us to zoom in and identify the B cells that have recognised cancer cells, as well as the antibodies they are producing. This will allow us to develop anti-cancer antibody treatments similar to the ones the B cells produce, which can then be given as a personalised treatment to boost the immune system’s response against breast cancer that has spread.”

The study was conducted alongside academics from the University of Oxford and University of Cambridge.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in